Delving into the Latest Updates on Phage Pharmaceuticals, Inc. with Synapse

概览

关联

2

项与 Phage Pharmaceuticals, Inc. 相关的临床试验

NCT00916292

/ Unknown status临床1期

A Phase 1a, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Normal Volunteers Given Punch Skin Biopsies

The purpose of the study is to see if FGF-1 is safe when applied topically to the surface of a wound.

开始日期2012-11-01

申办/合作机构

Phage Pharmaceuticals, Inc.

NCT00489294

/ Completed临床1期

An Open-Label Study of the Pharmacokinetics and Pharmacodynamics of Syntropin (a Human Growth Hormone) in Growth Hormone-Suppressed Healthy Volunteers

The purpose of this study is to evaluate the pharmacokinetics of Syntropin (a human growth hormone) and to determine the serum concentration of IGF-1 after Syntropin injection.

开始日期2004-08-01

申办/合作机构

Phage Pharmaceuticals, Inc.

100 项与 Phage Pharmaceuticals, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Phage Pharmaceuticals, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Phage Pharmaceuticals, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Phage Pharmaceuticals, Inc. 相关的转化医学

登录后查看更多信息